1.
Kockerols CC, Geelen I, Levin M-D, Janssen JJ, Dinmohamed AG, Hoogendoorn M, Cornelissen JJ, Westerweel PE. The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era. haematol [Internet]. 2022Aug.1 [cited 2024Apr.23];107(8):1940-3. Available from: https://haematologica.org/article/view/haematol.2021.280501